Login / Signup

Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs.

Elisabetta DegasperiEnrico GalmozziSerena PelusiRoberta D'AmbrosioRoberta SoffrediniMarta BorghiRiccardo PerbelliniFloriana FacchettiMassimo IavaroneAngelo SangiovanniLuca Vittorio ValentiPietro Lampertico
Published in: Hepatology (Baltimore, Md.) (2020)
In a large cohort of DAA-treated patients with cirrhotic HCV, GRS was associated with de novo HCC independently of classical risk factors, including liver disease severity. These data suggest that hepatic fat (i.e., lipotoxicity) promotes HCC in this setting and may represent a target for chemoprevention. Combination of clinical and genetic predictors may improve HCC risk stratification.
Keyphrases